Related Experiment Video
Updated: May 31, 2026

Detection of Protein Palmitoylation in Cultured Hippocampal Neurons by Immunoprecipitation and Acyl-Biotin Exchange (ABE)
Published on: February 18, 2013
Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling
Yasser Heakal1, Matthew P Woll, Todd Fox
1The Pennsylvania State University College of Medicine, Hershey, PA USA.
Abstract:
Neurotensin receptor-1 (NTSR-1) is a G-protein coupled receptor (GPCR) that has been recently identified as a mediator of cancer progression. NTSR-1 and its endogenous ligand, neurotensin (NTS), are co-expressed in several breast cancer cell lines and breast cancer tumor samples. Based on our previously published study demonstrating that intact structured membrane microdomains (SMDs) are required for NTSR-1 mitogenic signaling, we hypothesized that regulated receptor palmitoylation is responsible for NTSR-1 localization and signaling within SMDs upon NTS stimulation. Site-directed mutagenesis and pharmacological strategies were utilized to assess NTRS-1 post-translational modifications in an over-expression cell model (HEK293T) as well as a native breast cancer cell model (MDA-MB-231). NTSR-1 palmitoylation was confirmed by multiple chemical and fluororadiographic methodologies. NTSR-1 glycosylation was confirmed by pharmacological (tunicamycin) and chemical (PGNaseF and O-type glycosidase) approaches. Physiological correlates including cell viability (MTS assay), apoptosis (caspase 3/7 assay) and ERK phosphorylation were utilized to assess the consequences of NTRS-1 palmitoylation. The interaction between palmitoylated NTRS-1 and Gαq/11 within SMDS was confirmed with immunopreciptation analysis of detergent-free isolated fractions of caveolin-rich microdomains. We identified dual-palmitoylation at Cys381 and Cys383 of endogenously-expressed NTSR-1 in MDA-MB-231 breast adeno-carcinomas as well as exogenously-expressed NTSR-1 in HEK293T cells (which do not normally express NTSR-1). Pharmacological inhibition of NTSR-1 palmitoylation in MDA-MB-231 cells as well as NTSR-1-expressing HEK293T cells diminished NTS-mediated ERK 1/2 phosphorylation. Additionally, NTSR-1 mutated at Cys381 and Cys383 showed diminished ERK1/2 stimulation and reduced ability to protect HEK293T cells against apoptosis induced by serum starvation. Mechanistically, mutated C381,383S-NTSR-1 showed reduced ability to interact with Gαq/11 and diminished localization to structured membrane microdomains (SMDs), where Gαq/11 preferentially resides. We also demonstrated that only glycosylated isoforms of NTRS-1 localize within SMDs by palmitotylation. Collectively, our data establish palmitoylation as a novel pharmacological target to inhibit NTSR-1 mitogenic signaling in breast cancer cells.
Insights
Neurotensin receptor-1 (NTSR-1) palmitoylation is crucial for its signaling in breast cancer. Inhibiting this process offers a potential therapeutic strategy to block cancer progression by disrupting NTSR-1
Area of Science:
- Molecular and Cellular Biology
- Cancer Research
- Biochemistry
Background:
- Neurotensin receptor-1 (NTSR-1), a G-protein coupled receptor (GPCR), is implicated in mediating cancer progression.
- NTSR-1 and its ligand neurotensin (NTS) are co-expressed in breast cancer tissues.
- Structured membrane microdomains (SMDs) are essential for NTSR-1 mitogenic signaling.
Purpose of the Study:
- To investigate the role of NTSR-1 palmitoylation in its localization and signaling within SMDs.
- To determine if inhibiting NTSR-1 palmitoylation can impede breast cancer progression.
Main Methods:
- Site-directed mutagenesis and pharmacological strategies were used to study NTSR-1 post-translational modifications.
- Palmitoylation and glycosylation of NTSR-1 were confirmed using various chemical and fluororadiographic methods.
- Cell viability, apoptosis, and ERK phosphorylation assays assessed the functional consequences of NTSR-1 palmitoylation.
Main Results:
- NTSR-1 undergoes dual-palmitoylation at Cys381 and Cys383, confirmed in both cancer and overexpression cell models.
- Inhibition of NTSR-1 palmitoylation reduced NTS-mediated ERK1/2 phosphorylation.
- Mutations at Cys381 and Cys383 diminished NTSR-1's interaction with Gαq/11 and its localization to SMDs.
Conclusions:
- Palmitoylation is essential for NTSR-1 localization within SMDs and subsequent signaling.
- Targeting NTSR-1 palmitoylation presents a novel therapeutic strategy for inhibiting breast cancer progression.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Regulation of Nuclear Protein Sorting
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Directing Proteins to the Rough Endoplasmic Reticulum
Tail-anchoring of Proteins in the ER Membrane

